Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294-0022, USA.
J Clin Hypertens (Greenwich). 2011 Jul;13(7):479-86. doi: 10.1111/j.1751-7176.2011.00464.x. Epub 2011 Apr 22.
The authors analyzed data on 9950 participants taking antihypertensive medications in the nationwide Reasons for Geographic and Racial Differences in Stroke (REGARDS) study to determine the association between medication adherence and incident stroke symptoms. Medication adherence was assessed using a validated 4-item self-report scale and participants were categorized into 4 groups (scores of 0, 1, 2, and 3 or 4, with higher scores indicating worse adherence). The incidence of 6 stroke symptoms (sudden weakness on one side of the body, numbness, painless loss of vision in one or both eyes, loss of half vision, losing the ability to understand people, and losing the ability to express oneself verbally or in writing) was assessed via telephone interviews every 6 months. During a median of 4 years, the incidence of any stroke symptom was 14.6%, 17.9%, 20.2%, and 24.9% among participants with adherence scores of 0, 1, 2, and 3 or 4, respectively (P<.001). The multivariable adjusted hazard ratio (95% confidence interval) for any stroke symptom associated with adherence scores of 1, 2, and 3 or 4, vs 0, was 1.20 (1.04-1.39), 1.23 (0.94-1.60), and 1.59 (1.08-2.33), respectively (P<.001). Worse adherence was also associated with higher multivariable adjusted hazard ratios for each of the 6 stroke symptoms.
作者分析了参与全国范围 Reasons for Geographic and Racial Differences in Stroke(REGARDS)研究的 9950 名服用抗高血压药物的参与者的数据,以确定药物依从性与中风症状之间的关联。药物依从性使用经过验证的 4 项自我报告量表进行评估,参与者分为 4 组(得分 0、1、2 和 3 或 4,得分越高表示依从性越差)。通过每 6 个月一次的电话访谈评估 6 种中风症状(身体一侧突然无力、麻木、一只或两只眼睛无痛失明、一半视力丧失、无法理解他人、无法用言语或书面表达自己)的发生率。在中位数为 4 年的时间里,药物依从性得分分别为 0、1、2 和 3 或 4 的参与者中,任何中风症状的发生率分别为 14.6%、17.9%、20.2%和 24.9%(P<.001)。多变量调整后的危险比(95%置信区间)表明,与依从性得分 0 相比,1、2 和 3 或 4 与任何中风症状相关的危险比分别为 1.20(1.04-1.39)、1.23(0.94-1.60)和 1.59(1.08-2.33)(P<.001)。药物依从性越差,与 6 种中风症状中的每种症状相关的多变量调整后的危险比也越高。